Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1α

R Ravi, B Mookerjee, ZM Bhujwalla… - Genes & …, 2000 - genesdev.cshlp.org
R Ravi, B Mookerjee, ZM Bhujwalla, CH Sutter, D Artemov, Q Zeng, LE Dillehay, A Madan
Genes & development, 2000genesdev.cshlp.org
The switch to an angiogenic phenotype is a fundamental determinant of neoplastic growth
and tumor progression. We demonstrate that homozygous deletion of the p53 tumor
suppressor gene via homologous recombination in a human cancer cell line promotes the
neovascularization and growth of tumor xenografts in nude mice. We find that p53 promotes
Mdm2-mediated ubiquitination and proteasomal degradation of the HIF-1α subunit of
hypoxia-inducible factor 1 (HIF-1), a heterodimeric transcription factor that regulates cellular …
The switch to an angiogenic phenotype is a fundamental determinant of neoplastic growth and tumor progression. We demonstrate that homozygous deletion of the p53 tumor suppressor gene via homologous recombination in a human cancer cell line promotes the neovascularization and growth of tumor xenografts in nude mice. We find that p53 promotes Mdm2-mediated ubiquitination and proteasomal degradation of the HIF-1α subunit of hypoxia-inducible factor 1 (HIF-1), a heterodimeric transcription factor that regulates cellular energy metabolism and angiogenesis in response to oxygen deprivation. Loss of p53 in tumor cells enhances HIF-1α levels and augments HIF-1-dependent transcriptional activation of the vascular endothelial growth factor (VEGF) gene in response to hypoxia. Forced expression of HIF-1α in p53-expressing tumor cells increases hypoxia-induced VEGF expression and augments neovascularization and growth of tumor xenografts. These results indicate that amplification of normal HIF-1-dependent responses to hypoxia via loss of p53 function contributes to the angiogenic switch during tumorigenesis.
genesdev.cshlp.org